Thursday, 15 October 2026European Markets

REXEL And DASSAULT SYSTEMES Have A High Dividend Yield And Return On Equity In The Technology Sector.

Loading stream...

(vianews) - rexel (rxl.pa) is among this list of stock assets with the highest dividend rate and return on equity on the technology sector.

financial asset price forward dividend yield return on equity
rexel (rxl.pa) €19.12 3.73% 18.74%
dassault systemes (dsy.pa) €36.52 0.58% 13.1%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. rexel (rxl.pa)

3.73% forward dividend yield and 18.74% return on equity

rexel s.a., together with its subsidiaries, engages in distribution of low and ultra-low voltage electrical products and services for the residential, commercial, and industrial energy markets in france, europe, north america, and asia-pacific. the company offers smart cameras, sensors, controllers, and monitoring software; light sources, lights, and control switches; climate control products, including heat pumps, air conditioning, and water heaters; fire alarms, surveillance equipment, access controls devices, and emergency lightings; and connection cables, and switches and routers, as well as enclosures, mounts, and racks. it also provides solar modules and inverters; connected lighting, intelligent home system, home control touch screen, and smart thermostat products; residential chargers, commercial stations, and charging cables for electric vehicles; electric motors, variable speed drives, programmable logic controllers, and computers and operator interface; and fastening systems, electrical power and control, and valves and instrumentation products. the company offers products, services, and solutions in the fields of technical supply, automation, and energy management related to the construction, renovation, maintenance, and production. it operates a network of approximately 1,900 branches in 21 countries. the company was founded in 1967 and is headquartered in paris, france.

earnings per share

as for profitability, rexel has a trailing twelve months eps of €3.03.

pe ratio

rexel has a trailing twelve months price to earnings ratio of 6.31. meaning, the purchaser of the share is investing €6.31 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.74%.

more news about rexel.

2. dassault systemes (dsy.pa)

0.58% forward dividend yield and 13.1% return on equity

dassault systèmes se provides software solutions and services worldwide. it offers solidworks design software for mechanical and electronic printed circuit board design solutions, product data management, simulation, manufacturing, and technical communication; catia, an engineering and design software for product 3d computer-aided design; geovia for intersection of natural resources, infrastructure and urban planning; and biovia that develops chemicals, biologics, and materials experiences. the company provides simulia that delivers realistic simulation applications; delmia, which enables global industrial operations; 3dvia that provides 3d space planning solutions; and enovia that enables to plan and track the definition of success for customer. in addition, it offers centric plm, a product lifecycle management software solution; 3dexcite, a real-time 3d visualization software; netvibes, which enables organizations to gather, align, and enrich big data; 3dexperience platform that provides organizations a holistic and real-time view of their business activities and ecosystem, as well as connecting people, ideas, data, and solutions together in a single environment; and medidata, a clinical research study software that provides evidences and insights to pharmaceutical, biotech, medical device, and diagnostic companies, as well as academic researchers. it primarily serves companies in the transportation and mobility; industrial equipment; aerospace and defense; high-tech; life sciences and healthcare; energy and materials; home and lifestyle; construction, cities, and territories; consumer packaged goods and retail; marine and offshore; and business services. dassault systèmes se was incorporated in 1981 and is headquartered in vélizy-villacoublay, france.

earnings per share

as for profitability, dassault systemes has a trailing twelve months eps of €0.7.

pe ratio

dassault systemes has a trailing twelve months price to earnings ratio of 52.17. meaning, the purchaser of the share is investing €52.17 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.1%.

volatility

dassault systemes's last week, last month's, and last quarter's current intraday variation average was a negative 0.19%, a negative 0.27%, and a positive 1.15%.

dassault systemes's highest amplitude of average volatility was 1.08% (last week), 1.29% (last month), and 1.15% (last quarter).

more news about dassault systemes.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com